NovaBiotics, based in Aberdeen, is a drug design company which plans to commercialise a new class of antimicrobial peptide therapies.
Dr Barbara Blaney, Director, BIA Scotland, said: “With a strong presentation on their core technology platform, strategy for market and competitor awareness, as a ‘clinic-ready’ company, Novabiotics was chosen unanimously by the panel as winner.”
The BIA Thistle Bioscience Forum attracted the life sciences community from the UK and beyond to discuss the secrets for success through collaborations, deals and new ventures. With business development so key to company growth in the current economic climate, the Forum focused on funding opportunities, collaborations, licensing, working with big pharma and the research councils.
Dr Barbara Blaney, Director, BIA Scotland, said: “The life sciences sector has been, and can continue to be, an economic success story for Scotland. It is so encouraging to see the wealth of talent driving the industry forward.”
Life Sciences in Scotland
The life sciences sector is an economic success story for Scotland with 600 companies and institutions employing over 30,500 people (source: Scottish Enterprise)
BioIndustry Association
Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterprise trades.
With over 300 members, the BIA supports a wide range of sectors, majoring on the human health benefits of the technology and represents the interests of these innovative companies to a broad section of stakeholders from patient groups to politicians, advancing its members interests both within the UK and internationally to create a healthy UK bioscience sector which benefits society. For further information, please go to: www.bioindustry.org
